References
Shoda J, He BF, Tanaka N, Matsuzaki Y, Yamamori S, Osuga T (1995) Primary dual defect of cholesterol and bile acid metabolism in liver of patients with intrahepatic calculi. Gastroenterology 108:1534–1546
Hughes GR, Harris NN, Gharavi AE (1986) The anticardiolipin syndrome. J Rheumatol 13:486–489
Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GR (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2:1211–1214
Takano S, Abe Y, Hiratsuka I (1999) A case of antiphospholipid syndrome with acute myocardial infarction, portal and sinus thrombosis. Jpn Circ J 63:794–795 (in Japanese)
Kato J, Matsumura O, Nakamura F (1999) A case of antiphospholipid syndrome with superior mesenteric artery and venous thrombosis, and renal dysfunction. Nippon Jinzou Gakkai Shi 41:630–632 (in Japanese)
Mork H, Weber P, Schmidt H, Goerig RM, Scheurlen M (1998) Cavernous transformation of the portal vein associated with common bile duct strictures:report of two cases. Gastrointest Endosc 47:79–83
Greavis M (1999) Antiphospholipid antibodies and thrombosis. Lancet 353:1348–1353
Santiago MB, Cossermelli WA, Tuma MF (1989) Anticardiolipin antibodies in patients with infectious disease. Clin Rheumatol 8:23–28
Bick RL, Baker WF (1992) Anticardiolipin antibodies and thrombosis. Hematol Oncol Clin North Am 6:1287–1299
Hmilton ME (1991) Superior mesenteric artery thrombosis associated with antiphospholipid syndrome. West J Med 155:174–176
Warren S, Eberhard TP (1935) Mesenteric vein thrombosis. Surg Gynecol Obstet 61:102–121
Higa M, Kojima M, Ohnuma S, Hamanaka S, Yamamuro W, Sugiura H, Sato M (2001) Portal and mesenteric vein and vena cava thrombosis associated with antiphospholipid syndrome. Intern Med 40:1245–1249
De Gaetano AM, Lafortune M, Patriquin H, De Franco A, Aubin B, Paradis K (1995) Cavernous transformation of the portal vein. AJR 165:1151–1155
Heon JUL, Won P, Jae Chun C (1997) Mesenteric and portal venous obstruction associated with primary antiphospholipid antibody syndrome. J Gastroenterol Hepatol 12:822–826
Bayraktar Y, Balkanci F, Ozenc A, Arslan S, Koseoglu T, Ozdemir A, Uzunalimoglu B, Telatar H, Gurakar A, Van Thiel DH (1995) The “pseudo-cholangiocarcinoma sign” in patients with cavernous transformation of the portal vein and its effect on the serum alkaline phosphatase and bilirubin levels. Am J Gastroenterol 90:2015–2019
Bechtelsheimer H, Conrad A (1980) Morphologisches bild der cavernosen transformation der Pfortader. Leber Magen Darm 2:99–106
Shimada H, Niimoto S, Matsuba A, Isobe YU, Miwa K, Nakagawa G (1985) Primary cholesterol hepatolithiasis. J Jpn Soc Clin Surg 46:442–447
Akiyama T, Nakagawa T, Kanno M, Ohta T, Ueno K, Higashino Y, Konishi I, Miyazaki I, Uogishi M, Sodani H (1990) A clinicopathological study on intrahepatic cholesterol gallstones. Jpn J Surg 20:530–536
Vlahcevic ZR, Bell CC, Swell L (1970) Significance of the liver in the production of lithogenic bile in man. Gastroenterology 59:62–69
Lee SP, LaMont JT, Carey MC (1981) Role of gallbladder mucous hypersecretion in the evolution of cholesterol gallstones. J Clin Invest 67:1712–1723
Saji Y (1988) The effect of decreased portal blood flow on the biliary system. Jpn J Surg 18:558–568
Shoda J, Ueda T, Ikegami T, Matsuzaki Y, Satoh S, Kano M, Matsuura K, Tanaka N (1997) Increased biliary group phospholipase A2 and altered gallbladder bile in patients with multiple cholesterol stones. Gastroenterology 112:2036–2047
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Okudaira, K., Kawaguchi, A., Inoue, T. et al. Endoscopically Removed Hepatolithiasis Associated with Cavernous Transformation of the Portal Vein and Antiphospholipid Antibody Syndrome. Dig Dis Sci 51, 1952–1955 (2006). https://doi.org/10.1007/s10620-005-9059-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-9059-z